EDB Investments — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Mirxes Holding Companymirxes.comJul 2023

Mirxes develops RNA-based molecular diagnostics for early cancer detection, treatment selection, and multiomics research.

BiotechHealthtechMedical Devices

Co-investorsXeraya Capital Mitsui & Co

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.